nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—peripheral nervous system neoplasm—sarcoma	0.831	1	CtDrD
Isotretinoin—RARA—mammary gland—sarcoma	0.00165	0.0826	CbGeAlD
Isotretinoin—RARA—myometrium—sarcoma	0.00117	0.0586	CbGeAlD
Isotretinoin—RARG—hematopoietic system—sarcoma	0.00107	0.0535	CbGeAlD
Isotretinoin—RARA—hematopoietic system—sarcoma	0.00101	0.0503	CbGeAlD
Isotretinoin—RARG—skin of body—sarcoma	0.000931	0.0466	CbGeAlD
Isotretinoin—RXRB—cardiac atrium—sarcoma	0.000916	0.0458	CbGeAlD
Isotretinoin—RARB—tendon—sarcoma	0.000869	0.0434	CbGeAlD
Isotretinoin—RXRG—tendon—sarcoma	0.000849	0.0425	CbGeAlD
Isotretinoin—RARG—uterus—sarcoma	0.000809	0.0404	CbGeAlD
Isotretinoin—RXRB—tendon—sarcoma	0.000799	0.0399	CbGeAlD
Isotretinoin—RARA—uterus—sarcoma	0.000761	0.038	CbGeAlD
Isotretinoin—RXRA—liver—sarcoma	0.000757	0.0379	CbGeAlD
Isotretinoin—RARA—lymphoid tissue—sarcoma	0.000709	0.0354	CbGeAlD
Isotretinoin—RARG—tendon—sarcoma	0.000709	0.0354	CbGeAlD
Isotretinoin—RXRG—testis—sarcoma	0.000703	0.0352	CbGeAlD
Isotretinoin—RARB—liver—sarcoma	0.00068	0.034	CbGeAlD
Isotretinoin—RARA—tendon—sarcoma	0.000666	0.0333	CbGeAlD
Isotretinoin—RXRB—testis—sarcoma	0.000661	0.0331	CbGeAlD
Isotretinoin—RARA—bone marrow—sarcoma	0.000646	0.0323	CbGeAlD
Isotretinoin—RXRB—liver—sarcoma	0.000625	0.0313	CbGeAlD
Isotretinoin—RARG—testis—sarcoma	0.000587	0.0293	CbGeAlD
Isotretinoin—RARA—testis—sarcoma	0.000552	0.0276	CbGeAlD
Isotretinoin—RARA—liver—sarcoma	0.000522	0.0261	CbGeAlD
Isotretinoin—RARB—lymph node—sarcoma	0.000522	0.0261	CbGeAlD
Isotretinoin—RARG—lymph node—sarcoma	0.000425	0.0213	CbGeAlD
Isotretinoin—RARA—lymph node—sarcoma	0.0004	0.02	CbGeAlD
Isotretinoin—Pollakiuria—Epirubicin—sarcoma	8.2e-05	0.00055	CcSEcCtD
Isotretinoin—Hypersensitivity—Vincristine—sarcoma	8.19e-05	0.000549	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Epirubicin—sarcoma	8.1e-05	0.000543	CcSEcCtD
Isotretinoin—Paraesthesia—Etoposide—sarcoma	8.08e-05	0.000542	CcSEcCtD
Isotretinoin—Weight increased—Epirubicin—sarcoma	8.07e-05	0.000541	CcSEcCtD
Isotretinoin—Pancreatitis—Doxorubicin—sarcoma	8.05e-05	0.00054	CcSEcCtD
Isotretinoin—Weight decreased—Epirubicin—sarcoma	8.03e-05	0.000538	CcSEcCtD
Isotretinoin—Dyspnoea—Etoposide—sarcoma	8.02e-05	0.000538	CcSEcCtD
Isotretinoin—Somnolence—Etoposide—sarcoma	8e-05	0.000537	CcSEcCtD
Isotretinoin—Hypersensitivity—Mitoxantrone—sarcoma	7.97e-05	0.000535	CcSEcCtD
Isotretinoin—Asthenia—Vincristine—sarcoma	7.97e-05	0.000535	CcSEcCtD
Isotretinoin—Vomiting—Thiotepa—sarcoma	7.97e-05	0.000534	CcSEcCtD
Isotretinoin—Pneumonia—Epirubicin—sarcoma	7.96e-05	0.000534	CcSEcCtD
Isotretinoin—Drowsiness—Epirubicin—sarcoma	7.91e-05	0.000531	CcSEcCtD
Isotretinoin—Infestation NOS—Epirubicin—sarcoma	7.91e-05	0.000531	CcSEcCtD
Isotretinoin—Infestation—Epirubicin—sarcoma	7.91e-05	0.000531	CcSEcCtD
Isotretinoin—Vomiting—Dactinomycin—sarcoma	7.91e-05	0.00053	CcSEcCtD
Isotretinoin—Rash—Thiotepa—sarcoma	7.9e-05	0.00053	CcSEcCtD
Isotretinoin—Dermatitis—Thiotepa—sarcoma	7.89e-05	0.000529	CcSEcCtD
Isotretinoin—Headache—Thiotepa—sarcoma	7.85e-05	0.000526	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Epirubicin—sarcoma	7.84e-05	0.000526	CcSEcCtD
Isotretinoin—Rash—Dactinomycin—sarcoma	7.84e-05	0.000526	CcSEcCtD
Isotretinoin—Decreased appetite—Etoposide—sarcoma	7.82e-05	0.000525	CcSEcCtD
Isotretinoin—Renal failure—Epirubicin—sarcoma	7.78e-05	0.000521	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Etoposide—sarcoma	7.77e-05	0.000521	CcSEcCtD
Isotretinoin—Asthenia—Mitoxantrone—sarcoma	7.76e-05	0.000521	CcSEcCtD
Isotretinoin—Fatigue—Etoposide—sarcoma	7.76e-05	0.00052	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Epirubicin—sarcoma	7.75e-05	0.00052	CcSEcCtD
Isotretinoin—Stomatitis—Epirubicin—sarcoma	7.71e-05	0.000517	CcSEcCtD
Isotretinoin—Pain—Etoposide—sarcoma	7.7e-05	0.000516	CcSEcCtD
Isotretinoin—Constipation—Etoposide—sarcoma	7.7e-05	0.000516	CcSEcCtD
Isotretinoin—Conjunctivitis—Epirubicin—sarcoma	7.69e-05	0.000516	CcSEcCtD
Isotretinoin—Urinary tract infection—Epirubicin—sarcoma	7.69e-05	0.000516	CcSEcCtD
Isotretinoin—Neutropenia—Doxorubicin—sarcoma	7.68e-05	0.000515	CcSEcCtD
Isotretinoin—Dysuria—Doxorubicin—sarcoma	7.68e-05	0.000515	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Doxorubicin—sarcoma	7.63e-05	0.000512	CcSEcCtD
Isotretinoin—Diarrhoea—Vincristine—sarcoma	7.6e-05	0.00051	CcSEcCtD
Isotretinoin—Sweating—Epirubicin—sarcoma	7.58e-05	0.000509	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—sarcoma	7.58e-05	0.000509	CcSEcCtD
Isotretinoin—Haematuria—Epirubicin—sarcoma	7.54e-05	0.000506	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—sarcoma	7.49e-05	0.000503	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—sarcoma	7.47e-05	0.000501	CcSEcCtD
Isotretinoin—Epistaxis—Epirubicin—sarcoma	7.46e-05	0.0005	CcSEcCtD
Isotretinoin—Nausea—Thiotepa—sarcoma	7.44e-05	0.000499	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—sarcoma	7.43e-05	0.000498	CcSEcCtD
Isotretinoin—Sinusitis—Epirubicin—sarcoma	7.42e-05	0.000498	CcSEcCtD
Isotretinoin—Feeling abnormal—Etoposide—sarcoma	7.42e-05	0.000497	CcSEcCtD
Isotretinoin—Diarrhoea—Mitoxantrone—sarcoma	7.4e-05	0.000497	CcSEcCtD
Isotretinoin—Nausea—Dactinomycin—sarcoma	7.39e-05	0.000495	CcSEcCtD
Isotretinoin—Agranulocytosis—Epirubicin—sarcoma	7.38e-05	0.000495	CcSEcCtD
Isotretinoin—Pneumonia—Doxorubicin—sarcoma	7.36e-05	0.000494	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Etoposide—sarcoma	7.36e-05	0.000494	CcSEcCtD
Isotretinoin—Dizziness—Vincristine—sarcoma	7.35e-05	0.000493	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—sarcoma	7.32e-05	0.000491	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—sarcoma	7.32e-05	0.000491	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—sarcoma	7.32e-05	0.000491	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	7.26e-05	0.000487	CcSEcCtD
Isotretinoin—Renal failure—Doxorubicin—sarcoma	7.2e-05	0.000483	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Doxorubicin—sarcoma	7.18e-05	0.000481	CcSEcCtD
Isotretinoin—Urticaria—Etoposide—sarcoma	7.15e-05	0.00048	CcSEcCtD
Isotretinoin—Haemoglobin—Epirubicin—sarcoma	7.14e-05	0.000479	CcSEcCtD
Isotretinoin—Stomatitis—Doxorubicin—sarcoma	7.13e-05	0.000478	CcSEcCtD
Isotretinoin—Abdominal pain—Etoposide—sarcoma	7.12e-05	0.000477	CcSEcCtD
Isotretinoin—Body temperature increased—Etoposide—sarcoma	7.12e-05	0.000477	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—sarcoma	7.12e-05	0.000477	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—sarcoma	7.12e-05	0.000477	CcSEcCtD
Isotretinoin—Hepatitis—Epirubicin—sarcoma	7.1e-05	0.000476	CcSEcCtD
Isotretinoin—Haemorrhage—Epirubicin—sarcoma	7.1e-05	0.000476	CcSEcCtD
Isotretinoin—Hypoaesthesia—Epirubicin—sarcoma	7.07e-05	0.000474	CcSEcCtD
Isotretinoin—Vomiting—Vincristine—sarcoma	7.06e-05	0.000474	CcSEcCtD
Isotretinoin—Pharyngitis—Epirubicin—sarcoma	7.05e-05	0.000473	CcSEcCtD
Isotretinoin—Sweating—Doxorubicin—sarcoma	7.02e-05	0.000471	CcSEcCtD
Isotretinoin—Urinary tract disorder—Epirubicin—sarcoma	7.01e-05	0.00047	CcSEcCtD
Isotretinoin—Rash—Vincristine—sarcoma	7.01e-05	0.00047	CcSEcCtD
Isotretinoin—Dermatitis—Vincristine—sarcoma	7e-05	0.000469	CcSEcCtD
Isotretinoin—Oedema peripheral—Epirubicin—sarcoma	7e-05	0.000469	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—sarcoma	6.98e-05	0.000468	CcSEcCtD
Isotretinoin—Urethral disorder—Epirubicin—sarcoma	6.96e-05	0.000467	CcSEcCtD
Isotretinoin—Headache—Vincristine—sarcoma	6.96e-05	0.000467	CcSEcCtD
Isotretinoin—Epistaxis—Doxorubicin—sarcoma	6.9e-05	0.000463	CcSEcCtD
Isotretinoin—Vomiting—Mitoxantrone—sarcoma	6.88e-05	0.000461	CcSEcCtD
Isotretinoin—Sinusitis—Doxorubicin—sarcoma	6.87e-05	0.000461	CcSEcCtD
Isotretinoin—Visual impairment—Epirubicin—sarcoma	6.84e-05	0.000459	CcSEcCtD
Isotretinoin—Agranulocytosis—Doxorubicin—sarcoma	6.83e-05	0.000458	CcSEcCtD
Isotretinoin—Rash—Mitoxantrone—sarcoma	6.82e-05	0.000458	CcSEcCtD
Isotretinoin—Dermatitis—Mitoxantrone—sarcoma	6.82e-05	0.000457	CcSEcCtD
Isotretinoin—Headache—Mitoxantrone—sarcoma	6.78e-05	0.000455	CcSEcCtD
Isotretinoin—Erythema multiforme—Epirubicin—sarcoma	6.71e-05	0.00045	CcSEcCtD
Isotretinoin—Eye disorder—Epirubicin—sarcoma	6.64e-05	0.000445	CcSEcCtD
Isotretinoin—Hypersensitivity—Etoposide—sarcoma	6.63e-05	0.000445	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—sarcoma	6.62e-05	0.000444	CcSEcCtD
Isotretinoin—Haemoglobin—Doxorubicin—sarcoma	6.6e-05	0.000443	CcSEcCtD
Isotretinoin—Nausea—Vincristine—sarcoma	6.6e-05	0.000443	CcSEcCtD
Isotretinoin—Flushing—Epirubicin—sarcoma	6.59e-05	0.000442	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—sarcoma	6.57e-05	0.000441	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—sarcoma	6.57e-05	0.000441	CcSEcCtD
Isotretinoin—Hypoaesthesia—Doxorubicin—sarcoma	6.54e-05	0.000438	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—sarcoma	6.52e-05	0.000437	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—sarcoma	6.49e-05	0.000435	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—sarcoma	6.47e-05	0.000434	CcSEcCtD
Isotretinoin—Asthenia—Etoposide—sarcoma	6.46e-05	0.000433	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—sarcoma	6.44e-05	0.000432	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—sarcoma	6.44e-05	0.000432	CcSEcCtD
Isotretinoin—Nausea—Mitoxantrone—sarcoma	6.43e-05	0.000431	CcSEcCtD
Isotretinoin—Chills—Epirubicin—sarcoma	6.37e-05	0.000427	CcSEcCtD
Isotretinoin—Pruritus—Etoposide—sarcoma	6.37e-05	0.000427	CcSEcCtD
Isotretinoin—Arrhythmia—Epirubicin—sarcoma	6.34e-05	0.000425	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—sarcoma	6.33e-05	0.000425	CcSEcCtD
Isotretinoin—Alopecia—Epirubicin—sarcoma	6.28e-05	0.000421	CcSEcCtD
Isotretinoin—Mental disorder—Epirubicin—sarcoma	6.22e-05	0.000417	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—sarcoma	6.21e-05	0.000417	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—sarcoma	6.18e-05	0.000415	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—sarcoma	6.18e-05	0.000415	CcSEcCtD
Isotretinoin—Diarrhoea—Etoposide—sarcoma	6.16e-05	0.000413	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—sarcoma	6.14e-05	0.000412	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—sarcoma	6.13e-05	0.000411	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—sarcoma	6.1e-05	0.000409	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—sarcoma	6.09e-05	0.000409	CcSEcCtD
Isotretinoin—Tension—Epirubicin—sarcoma	6.07e-05	0.000407	CcSEcCtD
Isotretinoin—Nervousness—Epirubicin—sarcoma	6e-05	0.000403	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—sarcoma	5.98e-05	0.000401	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—sarcoma	5.96e-05	0.0004	CcSEcCtD
Isotretinoin—Dizziness—Etoposide—sarcoma	5.95e-05	0.000399	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—sarcoma	5.9e-05	0.000395	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—sarcoma	5.87e-05	0.000394	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—sarcoma	5.83e-05	0.000391	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—sarcoma	5.81e-05	0.000389	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—sarcoma	5.76e-05	0.000386	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—sarcoma	5.74e-05	0.000385	CcSEcCtD
Isotretinoin—Vomiting—Etoposide—sarcoma	5.72e-05	0.000384	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—sarcoma	5.72e-05	0.000384	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—sarcoma	5.72e-05	0.000384	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—sarcoma	5.71e-05	0.000383	CcSEcCtD
Isotretinoin—Agitation—Epirubicin—sarcoma	5.68e-05	0.000381	CcSEcCtD
Isotretinoin—Rash—Etoposide—sarcoma	5.68e-05	0.000381	CcSEcCtD
Isotretinoin—Dermatitis—Etoposide—sarcoma	5.67e-05	0.00038	CcSEcCtD
Isotretinoin—Headache—Etoposide—sarcoma	5.64e-05	0.000378	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—sarcoma	5.64e-05	0.000378	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—sarcoma	5.61e-05	0.000376	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—sarcoma	5.57e-05	0.000374	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—sarcoma	5.56e-05	0.000373	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—sarcoma	5.54e-05	0.000372	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—sarcoma	5.53e-05	0.000371	CcSEcCtD
Isotretinoin—Palpitations—Epirubicin—sarcoma	5.46e-05	0.000366	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—sarcoma	5.43e-05	0.000364	CcSEcCtD
Isotretinoin—Cough—Epirubicin—sarcoma	5.39e-05	0.000362	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—sarcoma	5.39e-05	0.000362	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—sarcoma	5.36e-05	0.000359	CcSEcCtD
Isotretinoin—Nausea—Etoposide—sarcoma	5.35e-05	0.000359	CcSEcCtD
Isotretinoin—Hypertension—Epirubicin—sarcoma	5.34e-05	0.000358	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—sarcoma	5.31e-05	0.000356	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—sarcoma	5.29e-05	0.000355	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—sarcoma	5.26e-05	0.000353	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—sarcoma	5.26e-05	0.000353	CcSEcCtD
Isotretinoin—Myalgia—Epirubicin—sarcoma	5.26e-05	0.000353	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—sarcoma	5.26e-05	0.000353	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—sarcoma	5.24e-05	0.000352	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	5.23e-05	0.000351	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—sarcoma	5.2e-05	0.000349	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—sarcoma	5.16e-05	0.000346	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—sarcoma	5.15e-05	0.000345	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—sarcoma	5.13e-05	0.000344	CcSEcCtD
Isotretinoin—Confusional state—Epirubicin—sarcoma	5.09e-05	0.000341	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—sarcoma	5.05e-05	0.000339	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—sarcoma	5.05e-05	0.000338	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—sarcoma	5.05e-05	0.000338	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—sarcoma	5.03e-05	0.000337	CcSEcCtD
Isotretinoin—Infection—Epirubicin—sarcoma	5.01e-05	0.000336	CcSEcCtD
Isotretinoin—Cough—Doxorubicin—sarcoma	4.99e-05	0.000335	CcSEcCtD
Isotretinoin—Shock—Epirubicin—sarcoma	4.96e-05	0.000333	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—sarcoma	4.96e-05	0.000332	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—sarcoma	4.95e-05	0.000332	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—sarcoma	4.94e-05	0.000331	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—sarcoma	4.94e-05	0.000331	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—sarcoma	4.92e-05	0.00033	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—sarcoma	4.9e-05	0.000329	CcSEcCtD
Isotretinoin—Hyperhidrosis—Epirubicin—sarcoma	4.88e-05	0.000327	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—sarcoma	4.87e-05	0.000327	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—sarcoma	4.87e-05	0.000327	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—sarcoma	4.87e-05	0.000327	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—sarcoma	4.85e-05	0.000325	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	4.84e-05	0.000324	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—sarcoma	4.81e-05	0.000323	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—sarcoma	4.81e-05	0.000323	CcSEcCtD
Isotretinoin—Dry mouth—Doxorubicin—sarcoma	4.76e-05	0.000319	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—sarcoma	4.71e-05	0.000316	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—sarcoma	4.71e-05	0.000316	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—sarcoma	4.67e-05	0.000313	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—sarcoma	4.67e-05	0.000313	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—sarcoma	4.64e-05	0.000311	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—sarcoma	4.6e-05	0.000308	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—sarcoma	4.59e-05	0.000308	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—sarcoma	4.58e-05	0.000307	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—sarcoma	4.57e-05	0.000307	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—sarcoma	4.56e-05	0.000306	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—sarcoma	4.56e-05	0.000306	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—sarcoma	4.53e-05	0.000304	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—sarcoma	4.53e-05	0.000304	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—sarcoma	4.51e-05	0.000303	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—sarcoma	4.5e-05	0.000302	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—sarcoma	4.49e-05	0.000301	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—sarcoma	4.45e-05	0.000298	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—sarcoma	4.44e-05	0.000298	CcSEcCtD
Isotretinoin—Decreased appetite—Epirubicin—sarcoma	4.39e-05	0.000294	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—sarcoma	4.36e-05	0.000293	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—sarcoma	4.36e-05	0.000292	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—sarcoma	4.35e-05	0.000292	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—sarcoma	4.31e-05	0.000289	CcSEcCtD
Isotretinoin—Pain—Epirubicin—sarcoma	4.31e-05	0.000289	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.25e-05	0.000285	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—sarcoma	4.22e-05	0.000283	CcSEcCtD
Isotretinoin—Paraesthesia—Doxorubicin—sarcoma	4.19e-05	0.000281	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—sarcoma	4.16e-05	0.000279	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—sarcoma	4.16e-05	0.000279	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—sarcoma	4.15e-05	0.000278	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Epirubicin—sarcoma	4.13e-05	0.000277	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—sarcoma	4.11e-05	0.000276	CcSEcCtD
Isotretinoin—Decreased appetite—Doxorubicin—sarcoma	4.06e-05	0.000272	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—sarcoma	4.03e-05	0.00027	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—sarcoma	4.02e-05	0.00027	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—sarcoma	4.01e-05	0.000269	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—sarcoma	3.99e-05	0.000268	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—sarcoma	3.99e-05	0.000268	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—sarcoma	3.99e-05	0.000267	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—sarcoma	3.99e-05	0.000267	CcSEcCtD
Isotretinoin—Feeling abnormal—Doxorubicin—sarcoma	3.85e-05	0.000258	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Doxorubicin—sarcoma	3.82e-05	0.000256	CcSEcCtD
Isotretinoin—Hypersensitivity—Epirubicin—sarcoma	3.72e-05	0.000249	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—sarcoma	3.71e-05	0.000249	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—sarcoma	3.69e-05	0.000247	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—sarcoma	3.69e-05	0.000247	CcSEcCtD
Isotretinoin—Asthenia—Epirubicin—sarcoma	3.62e-05	0.000243	CcSEcCtD
Isotretinoin—Pruritus—Epirubicin—sarcoma	3.57e-05	0.000239	CcSEcCtD
Isotretinoin—Diarrhoea—Epirubicin—sarcoma	3.45e-05	0.000231	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—sarcoma	3.44e-05	0.000231	CcSEcCtD
Isotretinoin—Asthenia—Doxorubicin—sarcoma	3.35e-05	0.000225	CcSEcCtD
Isotretinoin—Dizziness—Epirubicin—sarcoma	3.34e-05	0.000224	CcSEcCtD
Isotretinoin—Pruritus—Doxorubicin—sarcoma	3.3e-05	0.000221	CcSEcCtD
Isotretinoin—Vomiting—Epirubicin—sarcoma	3.21e-05	0.000215	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—sarcoma	3.19e-05	0.000214	CcSEcCtD
Isotretinoin—Rash—Epirubicin—sarcoma	3.18e-05	0.000213	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—sarcoma	3.18e-05	0.000213	CcSEcCtD
Isotretinoin—Headache—Epirubicin—sarcoma	3.16e-05	0.000212	CcSEcCtD
Isotretinoin—Dizziness—Doxorubicin—sarcoma	3.09e-05	0.000207	CcSEcCtD
Isotretinoin—Nausea—Epirubicin—sarcoma	3e-05	0.000201	CcSEcCtD
Isotretinoin—Vomiting—Doxorubicin—sarcoma	2.97e-05	0.000199	CcSEcCtD
Isotretinoin—Rash—Doxorubicin—sarcoma	2.94e-05	0.000197	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—sarcoma	2.94e-05	0.000197	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—sarcoma	2.92e-05	0.000196	CcSEcCtD
Isotretinoin—Nausea—Doxorubicin—sarcoma	2.77e-05	0.000186	CcSEcCtD
